National Health Research Ethics Committee, Nigeria, has finally approved the use of an experimental Ebola drug, Zmapp, for treatment of patients infected with the virus. The committee is research scientists, is a national body under the Federal Ministry of Health.
The Approval is contained in a statement issued to newsmen by Prof. Clement Adebawomo, Chairman of the committee on Wednesday (Today) in Abuja.
The decision by the committee is actually coming on the heels of Tuesday’s approval by the World Health Organisation (WHO) on the use of the drug, Zmapp for treatment
“It is ethical to use these treatments in the current situation without first submitting an application to National, State or Institutional Health Research Ethics Committee for prior review and approval.
“In addition, the Committee waives the current requirement that international shipment of any biological samples out of Nigeria should be preceded by the establishment of a Materials Transfer Agreement.
“This waiver is to promote rapid international response to this global emergency,’’ the statement said.
of Ebola patients.
According to the statement, the documentation can form the basis for clinical trials of the efficacy and side effects of the treatment based on established scientific principles.
“The guideline will contribute to preparedness in case of future occurrences and contribution to scientific knowledge.
“It must be noted that all Phase O and Phase I Clinical Trials that may subsequently be designed for treatment of this infection can be approved only by the National Health Research Ethics Committee,’’ it said.